Search by Drug Name or NDC

    NDC 52083-0639-16 G-TUSICOF 20; 400; 10 mg/5mL; mg/5mL; mg/5mL Details

    G-TUSICOF 20; 400; 10 mg/5mL; mg/5mL; mg/5mL

    G-TUSICOF is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Kramer Novis. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 52083-0639
    Product ID 52083-639_3e6452b2-a583-47e7-a0e8-cc70045a7383
    Associated GPIs 43997303100980
    GCN Sequence Number 066799
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 400-20-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 29196
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name G-TUSICOF
    Proprietary Name Suffix n/a
    Non-Proprietary Name dextromethorphan, guaifenesin, and phenylephrine
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 20; 400; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Kramer Novis
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 52083-0639-16 (52083063916)

    NDC Package Code 52083-639-16
    Billing NDC 52083063916
    Package 474 mL in 1 BOTTLE (52083-639-16)
    Marketing Start Date 2019-11-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL d169585f-b4f4-4831-8c71-e1533ae7e7c4 Details

    Revised: 11/2019